🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Will Q1 Earnings Hold A Surprise For Rite Aid (RAD) Stock?

Published 06/07/2016, 09:46 PM
Updated 07/09/2023, 06:31 AM
STZ
-
NWL
-
WBA
-
PEP
-
US90274J5618=UBSS
-

Drug store retailer, Rite Aid Corporation (NYSE:RAD) is slated to report first-quarter fiscal 2017 results on Jun 16, before the opening bell. In the last quarter, the company delivered a positive earnings surprise of 16.7%.

In fact, the company has delivered an average positive earnings surprise of 42.5% in the trailing four quarters. Rite Aid’s bottom line beat the Zacks Consensus Estimate in each of the last four quarters. Let’s see how things are shaping up for this announcement.

RITE AID CORP Price and Consensus

RITE AID CORP Price and Consensus | RITE AID CORP Quote

Factors Influencing This Quarter

Though Rite Aid’s impressive earnings surprise history as well as year-over-year top-line growth indicate strong fundamentals, we remain skeptical about the company’s lower-than-expected sales results in the past two quarters. The top line miss in the fourth quarter of fiscal 2016 was attributable to a soft performance at the Retail Pharmacy segment, which was somewhat offset by the results of the Pharmacy Services segment.

Moreover, the company’s comparable store sales (comps) trend suddenly turned negative since Dec 2015. Comps declined 0.6% in the fourth quarter owing to decrease in front-end and pharmacy comps. Additionally, the company held back its forecast for fiscal 2017 due to the pending merger agreement with Walgreens Boots Alliance (NASDAQ:WBA). These factors raise concerns regarding the company’s near-term growth prospects. Also, risks related to increased industry consolidation and greater competition is likely to hurt results.

Earnings Whispers

Our proven model does not conclusively show that Rite Aid is likely to beat on earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1, 2 or 3 for this to happen. This is not the case here, as you will see below:

Zacks ESP: Rite Aid currently has an Earnings ESP of 0.00%. This is because both the Most Accurate estimate and the Zacks Consensus Estimate stand at 4 cents.

Zacks Rank: Rite Aid carries a Zacks Rank #3 (Hold). Though a favorable Zacks Rank increases the predictive power of ESP, the company’s ESP of 0.00% makes surprise prediction difficult.

We caution against stocks with a Zacks Rank #4 or 5 (Sell rated) going into the earnings announcement, especially when the company is seeing negative estimate revisions.

Stocks that Warrant a Look

Here are some companies which you may want to consider as our model shows that these have the right combination of elements to post an earnings beat this quarter:

Constellation Brands Inc. (NYSE:STZ) , slated to report earnings on Jun 30, has an Earnings ESP of +1.97% and a Zacks Rank #3.

Pepsico Inc. (NYSE:PEP) , expected to report earnings on Jul 14, has an Earnings ESP of +1.56% and a Zacks Rank #3.

Newell Brands Inc. (NYSE:NWL) , expected to report earnings on Jul 29, has an Earnings ESP of +1.39% and a Zacks Rank #1 (Strong Buy).



NEWELL BRANDS (NWL): Free Stock Analysis Report

PEPSICO INC (PEP): Free Stock Analysis Report

RITE AID CORP (RAD): Free Stock Analysis Report

CONSTELLATN BRD (STZ): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.